Digital health and life science seem like a match made in heaven, promising not just to increase patient adherence but boost engagement, improve outcomes, and add billions of dollars in incremental revenue over the next few years.
Yet to succeed in beyond the pill, life science companies must overcome a number of challenges. What’s the best way to structure Beyond The Product teams and build a business case for scaling successful initiatives? How can life science companies uncover the most promising opportunities and calculate the ROI they deliver to the broader organizations?
Digital Health and Life Science: Success Beyond the Pill
In our latest eBook, Digital Health: Scaling Pharma X.0—written by digital health expert Karl Hess—we explore how life science companies can develop effective beyond the product operating models.
Filled with tips on what works and what doesn’t—and best practices from industry leaders—this eBook will help life science companies:
- Establish a corporate structure and governance that makes it easy to pilot new initiatives
- Focus on the most promising areas for generating incremental revenue
- Drive wider-scale adoption of successful experiments
- Build sustainable, value-adding digital health services
Leah Hoffmann is BTG's Marketing & Content Strategist. A former journalist, Leah worked for Forbes.com and The Economist before joining BTG. She is passionate about clear thinking, sharp writing, and strong points of view.